Relatives of a person who died of Covid-19 at a crematorium on April 25, 2021 in Noida, India. (Photo: Sunil Ghosh/Hindustan Times via Getty Images)
As US Lifts Export Ban to Assist India, Biden Urged to 'Keep His Word' by Supporting Vaccine Patent Waiver
"This is a start. But not nearly enough. President Biden promised that intellectual property law would not block the Global South from producing the vaccine."
In the face of rising public pressure, the Biden administration on Sunday partially lifted export controls on raw materials for coronavirus vaccines in an effort to help India combat a surge that is overwhelming hospitals and threatening to derail nascent inoculation campaigns in developing countries.
While welcomed by progressives who have been pushing the Biden administration to shift critical resources to India--which is experiencing the worst Covid-19 wave in the world--the White House is facing calls to take more sweeping action by supporting an international effort to suspend coronavirus vaccine patents, a move advocates say would allow India and other countries to quickly ramp up production.
"This is a start. But not nearly enough," U.S. healthcare activist Ady Barkan said Sunday in response to the Biden administration's decision to relax an export ban that was preventing India from obtaining key materials for the production of its Covishield vaccine.
"President Biden promised that intellectual property law would not block the Global South from producing the vaccine," Barkan added. "He must keep his word. Millions of lives depend on his choice."
In an interview with Barkan during the 2020 presidential campaign, Biden vowed to not let intellectual property (IP) barriers prevent other countries from mass producing coronavirus vaccines.
"It lacks any human dignity, what we're doing," Biden said of his predecessor's refusal to participate in global vaccination initiatives. "So the answer is yes, yes, yes, yes, yes. And it's not only a good thing to do, it's overwhelmingly in our interest to do."
However, since taking office in January, the Biden administration has upheld Trump's opposition to India and South Africa's proposal to temporarily waive sections of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), a step that would allow generic manufacturers to replicate vaccine formulas and bolster global supply.
Thus far, the vast majority of vaccine doses have been administered in rich and upper-middle-income countries as production remains largely under the control of a small number of pharmaceutical companies.
The Revolving Door Project (RDP), a government watchdog group, said Sunday that the Biden administration's new effort to supply India--which more than 70 nations rely on for vaccines--with key raw materials as well as therapeutics, test kits, and ventilators is "an encouraging first step."
But RDP argued that in order to "truly bring an end to global pandemic's carnage in India and the rest of the Global South," Biden "must go further and support the TRIPS waiver to lift IP restrictions on Covid-19 vaccines and treatment."
Several U.S. members of Congress, including Sen. Bernie Sanders (I-Vt.) and Rep. Jan Schakowsky (D-Ill.), echoed that call during a virtual event on Friday as the World Trade Organization prepares to consider the waiver proposal once again next month.
"We have the tools to save human lives, and those tools should be readily available to all people," said Sanders. "Poor people in Africa, Asia, Latin America, and throughout the world have as much a right to be protected from the virus, to live, as people in wealthier nations. To me, this is not a huge debate, this is common human morality."
We are at a crossroads
This country and this world are at a monumental crossroads. In a few short weeks, US voters will have an opportunity to beat back the forces of fascism and confront the billionaires who are rigging the economy, our media system, and our democracy, making it increasingly impossible for ordinary people to get by. We’re not just talking about the election. We’re talking about what must be done once these fascist elements are vanquished from power. We need a bolder set of solutions than what either major party has so far been willing to offer and a working-class movement ready to fight like hell for it. Trump didn't emerge from nowhere. The conditions that fueled MAGA authoritarianism were created by decades of radical neoliberal economic policies and a corrupt political system dominated by corporate interests. They slashed taxes on the super-rich, promising that the benefits would trickle down. They said giveaways to the corporate titans would make life more affordable for the rest of us. It was all bullshit. And when a bitter, betrayed populace searches for someone to blame, right-wing demagogues have little trouble finding scapegoats. People know when they're being lied to, but you won't hear any of this from the corporate media. Only independent journalism—powered and funded by people who believe in building a better world—can deliver truly trustworthy daily news. Our Fall Campaign is underway, and we need your help. To power our newsroom through the rest of the year, we need to raise $125,000 by midnight on October 31. So if you share our vision, please contribute whatever you can to sustain our work. |
In the face of rising public pressure, the Biden administration on Sunday partially lifted export controls on raw materials for coronavirus vaccines in an effort to help India combat a surge that is overwhelming hospitals and threatening to derail nascent inoculation campaigns in developing countries.
While welcomed by progressives who have been pushing the Biden administration to shift critical resources to India--which is experiencing the worst Covid-19 wave in the world--the White House is facing calls to take more sweeping action by supporting an international effort to suspend coronavirus vaccine patents, a move advocates say would allow India and other countries to quickly ramp up production.
"This is a start. But not nearly enough," U.S. healthcare activist Ady Barkan said Sunday in response to the Biden administration's decision to relax an export ban that was preventing India from obtaining key materials for the production of its Covishield vaccine.
"President Biden promised that intellectual property law would not block the Global South from producing the vaccine," Barkan added. "He must keep his word. Millions of lives depend on his choice."
In an interview with Barkan during the 2020 presidential campaign, Biden vowed to not let intellectual property (IP) barriers prevent other countries from mass producing coronavirus vaccines.
"It lacks any human dignity, what we're doing," Biden said of his predecessor's refusal to participate in global vaccination initiatives. "So the answer is yes, yes, yes, yes, yes. And it's not only a good thing to do, it's overwhelmingly in our interest to do."
However, since taking office in January, the Biden administration has upheld Trump's opposition to India and South Africa's proposal to temporarily waive sections of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), a step that would allow generic manufacturers to replicate vaccine formulas and bolster global supply.
Thus far, the vast majority of vaccine doses have been administered in rich and upper-middle-income countries as production remains largely under the control of a small number of pharmaceutical companies.
The Revolving Door Project (RDP), a government watchdog group, said Sunday that the Biden administration's new effort to supply India--which more than 70 nations rely on for vaccines--with key raw materials as well as therapeutics, test kits, and ventilators is "an encouraging first step."
But RDP argued that in order to "truly bring an end to global pandemic's carnage in India and the rest of the Global South," Biden "must go further and support the TRIPS waiver to lift IP restrictions on Covid-19 vaccines and treatment."
Several U.S. members of Congress, including Sen. Bernie Sanders (I-Vt.) and Rep. Jan Schakowsky (D-Ill.), echoed that call during a virtual event on Friday as the World Trade Organization prepares to consider the waiver proposal once again next month.
"We have the tools to save human lives, and those tools should be readily available to all people," said Sanders. "Poor people in Africa, Asia, Latin America, and throughout the world have as much a right to be protected from the virus, to live, as people in wealthier nations. To me, this is not a huge debate, this is common human morality."
In the face of rising public pressure, the Biden administration on Sunday partially lifted export controls on raw materials for coronavirus vaccines in an effort to help India combat a surge that is overwhelming hospitals and threatening to derail nascent inoculation campaigns in developing countries.
While welcomed by progressives who have been pushing the Biden administration to shift critical resources to India--which is experiencing the worst Covid-19 wave in the world--the White House is facing calls to take more sweeping action by supporting an international effort to suspend coronavirus vaccine patents, a move advocates say would allow India and other countries to quickly ramp up production.
"This is a start. But not nearly enough," U.S. healthcare activist Ady Barkan said Sunday in response to the Biden administration's decision to relax an export ban that was preventing India from obtaining key materials for the production of its Covishield vaccine.
"President Biden promised that intellectual property law would not block the Global South from producing the vaccine," Barkan added. "He must keep his word. Millions of lives depend on his choice."
In an interview with Barkan during the 2020 presidential campaign, Biden vowed to not let intellectual property (IP) barriers prevent other countries from mass producing coronavirus vaccines.
"It lacks any human dignity, what we're doing," Biden said of his predecessor's refusal to participate in global vaccination initiatives. "So the answer is yes, yes, yes, yes, yes. And it's not only a good thing to do, it's overwhelmingly in our interest to do."
However, since taking office in January, the Biden administration has upheld Trump's opposition to India and South Africa's proposal to temporarily waive sections of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), a step that would allow generic manufacturers to replicate vaccine formulas and bolster global supply.
Thus far, the vast majority of vaccine doses have been administered in rich and upper-middle-income countries as production remains largely under the control of a small number of pharmaceutical companies.
The Revolving Door Project (RDP), a government watchdog group, said Sunday that the Biden administration's new effort to supply India--which more than 70 nations rely on for vaccines--with key raw materials as well as therapeutics, test kits, and ventilators is "an encouraging first step."
But RDP argued that in order to "truly bring an end to global pandemic's carnage in India and the rest of the Global South," Biden "must go further and support the TRIPS waiver to lift IP restrictions on Covid-19 vaccines and treatment."
Several U.S. members of Congress, including Sen. Bernie Sanders (I-Vt.) and Rep. Jan Schakowsky (D-Ill.), echoed that call during a virtual event on Friday as the World Trade Organization prepares to consider the waiver proposal once again next month.
"We have the tools to save human lives, and those tools should be readily available to all people," said Sanders. "Poor people in Africa, Asia, Latin America, and throughout the world have as much a right to be protected from the virus, to live, as people in wealthier nations. To me, this is not a huge debate, this is common human morality."